| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $35K | -100.0% |
| R&D Expense | $5.6M | -36.8% |
| SG&A Expense | $52.7M | +15.1% |
| Operating Income | -$49.2M | -131.1% |
| Pre-tax Income | -$49.1M | -116.0% |
| Income Tax | -$6.2M | -123.0% |
| Net Income | -$42.9M | -115.3% |
| EPS (Basic) | -$0.60 | -115.2% |
| EPS (Diluted) | -$0.60 |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $142.0M | -26.4% |
| Accounts Receivable | $17K | +112.5% |
| Current Assets | $169.5M | -24.5% |
| Total Assets | $186.5M | -20.6% |
| Current Liabilities | $1.0M | -90.1% |
| Total Liabilities | $1.1M | -89.7% |
| Stockholders' Equity | $185.4M | -17.4% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.7M | -118.4% |
| Capital Expenditures | $11K | — |
| Investing Cash Flow | $1.0M | +104.0% |
| Financing Cash Flow | -$196K | +99.7% |
| Free Cash Flow | -$51.7M | -118.4% |
| -115.3% |